Trial Profile
Evaluation of Outer Retinal Tubulations in Eyes Switched from Intravitreal Ranibizumab to Aflibercept in Patients with Exudative Age-related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 30 Aug 2017 New trial record